Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // July 21st, 2008 // 6:50 am
Welcome to the working week. Good to see you again. Hope your weekend was refreshing. Ours was quiet as we stuck to our knitting by doing some chores and tending to the shortest of the short people. Now, though, the routine reasserts itself. So grab your cup of whatever and dig in…
Sanofi Buys Vitamin Maker For $544M (Bloomberg News)
Glaxo Pays Biota $19M To Settle Relenza Suit (Bloomberg News)
Novartis Unit Recalling Prescription Eyedrops (The Associated Press)
Shire Cuts Tax Bill By Moving HQ (The Financial Times)
Enbrel & Alzheimer’s Causes More Criticism (Yahoo/Reuters)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Alzheimers, Amgen, Biota, Ed Tobinick, Edward Tobinick, Enbrel, GlaxoSmithKline, Novartis, Primary Health Care, Relenza, Sanofi Aventis, Shire Pharmaceuticals, Vitamins